These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31309883)

  • 1. Adenosine Receptors in Modulation of Central Nervous System Disorders.
    Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
    Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
    Gorain B; Choudhury H; Yee GS; Bhattamisra SK
    Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.
    Chiu GS; Freund GG
    Metabolism; 2014 Dec; 63(12):1491-8. PubMed ID: 25308443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors.
    Jamwal S; Mittal A; Kumar P; Alhayani DM; Al-Aboudi A
    Curr Pharm Des; 2019; 25(26):2892-2905. PubMed ID: 31333104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine receptor signaling: a key to opening the blood-brain door.
    Bynoe MS; Viret C; Yan A; Kim DG
    Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.
    Pasquini S; Contri C; Merighi S; Gessi S; Borea PA; Varani K; Vincenzi F
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A
    Kashfi S; Ghaedi K; Baharvand H; Nasr-Esfahani MH; Javan M
    Mol Neurobiol; 2017 Dec; 54(10):8128-8139. PubMed ID: 27889899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy.
    Fernandez M; Nigro M; Travagli A; Pasquini S; Vincenzi F; Varani K; Borea PA; Merighi S; Gessi S
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis.
    Shakya AK; Naik RR; Almasri IM; Kaur A
    Curr Pharm Des; 2019; 25(26):2875-2891. PubMed ID: 31333103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and regulation of adenosine in the central nervous system.
    Dunwiddie TV; Masino SA
    Annu Rev Neurosci; 2001; 24():31-55. PubMed ID: 11283304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective role of adenosine in the CNS.
    Wardas J
    Pol J Pharmacol; 2002; 54(4):313-26. PubMed ID: 12523485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine signaling mediate pain transmission in the central nervous system.
    Zhou M; Wu J; Chang H; Fang Y; Zhang D; Guo Y
    Purinergic Signal; 2023 Mar; 19(1):245-254. PubMed ID: 35000074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of endogenous adenosine levels in the CNS: potential for therapy in stroke, epilepsy and pain.
    Foster AC; Miller LP; Wiesner JB
    Adv Exp Med Biol; 1994; 370():427-30. PubMed ID: 7660943
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
    Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F
    Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of Adenosine Receptors: The State of the Art.
    Borea PA; Gessi S; Merighi S; Vincenzi F; Varani K
    Physiol Rev; 2018 Jul; 98(3):1591-1625. PubMed ID: 29848236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors.
    Cunha RA
    Neurochem Int; 2001 Feb; 38(2):107-25. PubMed ID: 11137880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and abnormal functions of adenosine receptors in the central nervous system revealed by genetic knockout studies.
    Wei CJ; Li W; Chen JF
    Biochim Biophys Acta; 2011 May; 1808(5):1358-79. PubMed ID: 21185258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.